Sat 24 Oct 2026 International edition
Clinical Trials & Research PepGen Advances PGN-EDODM1 to Maximum Planned Dose in Phase II FREEDOM2-DM1 Trial Following Favorable Safety Review
Clinical Trials & Research Strategic Pivot in Oncology: Context Therapeutics Axes CT-95 Program to Preserve Cash and Double Down on Pipeline Assets CTIM-76 and CT-202
Healthcare News & Policy Rewriting the Narrative of Obesity: How Modern Science is Dismantling the Myth of Willpower
Pathology & Histology Executive Overview
Laboratory Medicine Unlocking the Milky Way’s Most Powerful Particle Accelerators: Scientists Confirm Rare Proton “PeVatron”
Bio-Research & Life Sciences The Geometry of Thought: 60,000-Year-Old Ostrich Eggshells Reveal the Roots of Human Abstraction
Oncology & Cancer Research Breakthrough Research Suggests a Potential Permanent Cure for HIV in Newborns Within 72 Hours
Medical Devices & Lab Automation The Evolution of Minimally Invasive Care: Inside the 2026 MDO Min-Vasive Medtech Webinar Series
Precision Medicine Dual-Action Silica Nanoparticles Spark Complete Remissions in Aggressive Prostate Cancer Models, Paving the Way for Human Clinical Trials
Pathology & Histology Bridging the Digital Divide in Pathology: How Legacy Regulation Threatens the Future of Remote Cytopathology
Healthcare News & Policy Natural Relief on the Horizon: Daily Peppermint Oil Supplementation Shown to Reduce Mildly Elevated Blood Pressure in Landmark Study
Clinical Trials & Research Advancing Immunotherapy Frontiers: Dispatch Bio Doses First Patient in Phase I Trial of DISP-10 for Advanced Gastrointestinal Cancers

Archive

Tag: appointed